World Obesity Day 2025: Recent Developments and the Road Ahead
In January 2025, the FDA released updated guidance titled “Obesity and Overweight: Developing Drugs and Biological Products for Weight Reduction.” The FDA...
New FDA Guidance: Developing Drugs and Biological Products for Weight Reduction
Medpace medical, regulatory, and biostatistics experts identify key differences between the FDA’s 2007 and 2025 guidance documents on developing products...
[On-Demand Webinar] Revolutionizing Obesity Clinical Trials: A Patient-Centric Approach
In this webinar, Sr. Director of Clinical Trial Management Jennifer Brown and Advanced Clinical Practitioners Amanda Sylvester, DNP, APRN, CPNP-BC...
Key Learnings from European Congress on Obesity and ENDO
Discover key learning from the European Congress on Obesity and ENDO 2024 conferences.
Medpace Recognizes World Obesity Day
March 4th is World Obesity Day, a unified day of action that calls for a cohesive, cross-sector response to the...
[Webinar] Optimizing Study Execution in Obesity Clinical Trials: Considerations for Recruitment and Retention
In this webinar, hear from Medpace medical and operational experts as they address these unique challenges in the recruitment and retention of obesity participants and…